Professor Kevin Harrington

Professor Kevin Harrington is a renowned figure in the field of Oncology, particularly recognised for their expertise in head and neck cancer. Their work focuses on developing innovative treatments using biologically-targeted agents, such as viruses, antibodies, and small molecules. These treatments aim to selectively destroy cancer cells and activate anti-tumour immune responses.

Professor Harrington's research has been instrumental in advancing the field of cancer treatment. They have conducted extensive research on the use of viruses as anti-cancer agents and the development of new drugs that enhance the effectiveness of radiation therapy against cancer cells. Their work has been published in over 400 articles, highlighting their significant contributions to the field.

A testament to their dedication to improving patient outcomes, Professor Harrington's laboratory research is directly translated into clinical trials, primarily focusing on head and neck cancers and melanomas. This approach ensures that the latest scientific discoveries are rapidly applied to develop new and more effective treatments for patients.